A crucial aspect of regenerative medicine and drug discovery lies in the ability to expand human stem cell collections to sufficient quantities for therapeutic uses. Traditionally, restricted cell supply posed a significant obstacle to progress in these fields. Consequently, considerable effort has been directed towards optimizing protocols for ste